Short answer
Henry Schein (HSIC) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 26, 2026. Quarterly revenue was $3.5B (up 4.0% year over year) with net income of $119M.
Q3 2026 key financials · XBRL
- Revenue
- $3.5B
- +4.0% YoY · +0.4% QoQ
- Net income
- $119M
- +17.8% YoY · +26.6% QoQ
- Operating margin
- 5.6%
- Gross margin
- 31.8%
- EPS (diluted)
- $1.06
- +26.2% YoY · +29.3% QoQ
Source: XBRL data from the Henry Schein (HSIC) Q3 2026 10-Q on SEC EDGAR. USD.
Henry Schein Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $3,471M, up 4.0% YoY from $3,339M
- Gross margin 31.8% vs 30.7% YoY, with effective tax rate 23.1% vs 21.3%
- Best segment Global Specialty Products, sales up 6.1% to 11.3% of revenue
- Worst product line Global Value-Added Services, sales down 4.8%
- Nine-month operating cash flow $306M vs $331M, investing cash use $173M vs $253M
- Tariff refund benefit $28M in quarter, additional refunds expected in fourth quarter of 2026
Risk Factors
- No material changes from the December 27, 2025 Form 10-K risk factors
- Continued exposure to healthcare distribution competition and pricing pressure
- Continued regulatory and compliance requirements across healthcare markets
- Continued liquidity, credit, and foreign-currency risks from global operations
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Henry Schein quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.